ARTISTRY-1, NCT05502341: Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen |
|
|
| Recruiting | 2/3 | 671 | Europe, Canada, Japan, US, RoW | Bictegravir, GS-9883, Lenacapavir, GS-6207, BIC/LEN FDC, Stable Baseline Regimen | Gilead Sciences | HIV-1-infection | 01/26 | 11/28 | | |